Heidi Ko, Medical Director, Medical Affairs at Labcorp Drug Development, shared a post by Brian Caveney, Chief Medical and Scientific Officer at Laboratory Corporation of America on LinkedIn, adding:
“Cancer care is evolving incredibly fast, and as oncologists, we feel that complexity every day.
Biomarkers and personalized therapies continue to expand our treatment options and they reinforce the need for streamlined testing and actionable, timely results to achieve truly United by Unique care.
That’s why these insights resonate with me, and I’m proud to see us Labcorp leaning into feedback from clinicians to help make precision care more accessible.”
Quoting Brian Caveney‘s post:
“Cancer care is getting more complex, biomarker-driven, and personalized. Oncologists gave us insights into what they need to deliver better clinical outcomes.”
More posts featuring Heidi Ko on OncoDaily.